USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cofco Biotechnology Co., Ltd.

USPTO PatentsView assignee record - 8 granted patents across 15 technology areas, active 2021–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

10.1

Avg claims per patent

5-year filing velocity

The verdict

Cofco holds 8 US patents across 15 technology areas, rank #31,185 of 50,000 tracked assignees.

#31,185
of 50,000 US assignees by volume: Top 76%
by Innovation Score (27.4/100): 10.1
avg claims per patent

Portfolio overview

Cofco Biotechnology Co., Ltd. has been granted 8 US utility patents between 2021 and 2021, placing Cofco Biotechnology Co., Ltd. at rank #31,185 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.1 claims per patent with primary concentration in C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). As a Foreign Corporation, Cofco Biotechnology Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Cofco sits between CMC Corporation (8 patents, rank #31,181) and Colop Digital Gmbh (8 patents, rank #31,189) - the closest US assignees by grant volume. The composite Innovation Score of 27.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2021, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Cofco Biotechnology Co., Ltd.'s 10.1 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Cofco Biotechnology Co., Ltd. against peers pursuing similar technology classes.

CMC

8
CNH Industrial It…

8
Cobalt Extreme PTY

8
Coban

8
Cognitive Researc…

8
Col-ven

8
Colibri Heart Val…

8
Colop Digital

8
Cofco Biotechnolo… ◀

8

What this shows Cofco holds 8 patents at rank #31,185, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cofco

By rank, the assignees closest to #31,185 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise THAN BY React…)

Other assignees with the most granted patents in Cofco's primary technology class.

Cofco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

27 Top 76% higher than 24% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Cofco Biotechnology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	8	100.0%

Which technologies does Cofco Biotechnology Co., Ltd. patent most?

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 6

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 4

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 4

B01D - SEPARATION 3

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 1

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 1

B29B - PREPARATION OR PRETREATMENT OF THE MATERIAL TO BE SHAPED; MAKING GRANULES OR PREFORMS; RECOVERY OF PLASTICS OR OTHER CONSTITUENTS OF WASTE MATERIAL CONTAINING PLASTICS 1

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 1

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 1

C02F - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE 1

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 1

C12Y - ENZYMES 1

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Where it ranks

Overall rank by patents

#31,185

Across all tracked assignees

Innovation Score

27.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Cofco Biotechnology Co., Ltd. hold?

Cofco Biotechnology Co., Ltd. holds 8 US granted patents filed between 2021 and 2021, spanning 15 technology areas.

What is Cofco Biotechnology Co., Ltd.'s Innovation Score?

Cofco Biotechnology Co., Ltd. has an Innovation Score of 27.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cofco Biotechnology Co., Ltd. focus on?

Cofco Biotechnology Co., Ltd.'s top technology area is C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS) with 6 patents. The company has filed patents in 15 CPC subclasses total.

Is Cofco Biotechnology Co., Ltd.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cofco Biotechnology Co., Ltd..

What does claim depth mean for Cofco Biotechnology Co., Ltd.'s patents?

Cofco Biotechnology Co., Ltd.'s patents average 10.1 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Cofco Biotechnology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Cofco's 8 grants land it in the top 76% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Cofco ranks #31,185 of 50,000. Top 50 holders
Most of this portfolio concentrates in C08G - see who else leads that technology area. C08G leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.